TransMedics Group: UBS raises target price to $88 from $77
TMDX•UBS raised its target price for TransMedics Group to $88 from $77.
Related News
SABESP publishes third-quarter 2026 earnings call transcript
SBS•
NextEra Energy targets top end of 2026 adjusted EPS guidance of $3.92-$4.02
NEE•
United-Guardian Q3 net income more than triples to $930,912; net sales rise 54% to $3.49 million
UG•
STMicroelectronics announces status of common share repurchase program
STM•
Jasper Therapeutics announces results of offer to purchase warrants
JSPR•